Table 5.
Non-susceptibility rates of the most prevalent non-invasive bacterial pathogens from Gabon
| Pathogen (n) |
Antimicrobial non-susceptibility (%) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PEN/AMPa | COX | AMP + BLI | CRO | GEN | CIP | CHL | CLI | ERY | SXT | TCY | |
|
S. aureus (312) |
94.2 |
8.33 |
8.33 |
8.33 |
2.3 |
9.4 |
0.9 |
2.5 |
17.0 |
8.3 |
37.5 |
|
S. pyogenes (69) |
8.6 |
- |
- |
0 |
- |
- |
9.1 |
7.8 |
7.9 |
56.0 |
- |
|
S. pneumoniae (19) |
6.7 |
- |
- |
ND |
- |
- |
14.3 |
10.5 |
11.1 |
82.4 |
ND |
|
E. faecalis (19) |
0 |
- |
- |
- |
- |
81.3 |
- |
- |
- |
- |
- |
|
K. pneumoniae (56) |
100 |
- |
51.9 |
38.9 |
38.2 |
21.4 |
55.6 |
- |
- |
60 |
ND |
|
P. agglomerans (6) |
83.3 |
- |
75.5 |
ND |
0 |
0 |
ND |
- |
- |
0 |
ND |
|
P. aeruginosa (39) |
- |
- |
0b |
0c |
0d |
2.6 |
- |
- |
- |
- |
- |
|
P. mirabilis (52) |
34.6 |
- |
17.3 |
2.1 |
13.5 |
1.9 |
44.4 |
- |
- |
48.9 |
ND |
|
E. coli (114) |
80.4 |
- |
60.3 |
16.4 |
14.7 |
24.1 |
35.5 |
- |
- |
88.1 |
ND |
| S. enterica (9) | 22.2 | - | ND | 0 | 0 | 0 | 0 | - | - | 12.5 | 0 |
Note: Abbrevations are penicillin/ampicillin (PEN/AMP), cefoxitin (COX), ampicillin plus betalactamase-inhibitor (AMP + BLI), ceftriaxone (CRO), gentamicin (GEN), ciprofloxacin (CIP), chloramphenicol (CHL), clindamycin (CLI), erythromycin (ERY), cotrimoxazole (SXT), tetracycline (TCY), not done (ND). Non-susceptible isolates are shown as the percentage of tested isolates.
aShown is the non-susceptibility of Gram-positives to penicillin and the non-susceptibility of Gram-negatives and E. faecalis to ampicillin.
bNon-susceptibility to piperacillin/tazobactam.
cNon-susceptibility to ceftazidim.
dNon-susceptibility to amikacin.